Ocuphire Pharma Price to Book Ratio 2010-2024 | IRD

Historical price to book ratio values for Ocuphire Pharma (IRD) over the last 10 years. The current price to book ratio for Ocuphire Pharma as of October 24, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Ocuphire Pharma Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2024-10-24 1.13 0.72
2024-06-30 1.53 $1.56 0.98
2024-03-31 2.01 $1.84 1.09
2023-12-31 3.01 $2.08 1.45
2023-09-30 3.35 $2.44 1.37
2023-06-30 4.34 $1.80 2.42
2023-03-31 3.75 $1.97 1.90
2022-12-31 3.53 $2.22 1.59
2022-09-30 2.01 $0.57 3.52
2022-06-30 1.92 $0.73 2.64
2022-03-31 3.24 $0.90 3.60
2021-12-31 3.73 $1.18 3.16
2021-09-30 5.15 $1.19 4.33
2021-06-30 5.28 $1.34 3.95
2021-03-31 5.81 $0.90 6.47
2020-12-31 6.49 $-1.24 -5.24
2020-09-30 8.32 $5.10 1.63
2020-06-30 11.36 $6.97 1.63
2020-03-31 7.20 $9.40 0.77
2019-12-31 7.64 $-2.65 -2.88
2019-09-30 8.20 $11.70 0.70
2019-06-30 20.64 $13.56 1.52
2019-03-31 24.48 $15.86 1.54
2018-12-31 44.64 $13.53 3.30
2018-09-30 85.44 $9.70 8.81
2018-06-30 67.68 $17.28 3.92
2018-03-31 72.48 $22.65 3.20
2017-12-31 96.96 $25.38 3.82
2017-09-30 116.16 $25.51 4.55
2017-06-30 137.28 $26.84 5.12
2017-03-31 244.80 $2.21 110.57
2016-12-31 68.11 $34.51 1.97
2016-09-30 100.80 $34.88 2.89
2016-06-30 120.58 $35.61 3.39
2016-03-31 158.45 $38.77 4.09
2015-12-31 174.24 $45.67 3.82
2015-09-30 249.60 $47.04 5.31
2015-06-30 291.70 $56.97 5.12
2015-03-31 350.40 $62.64 5.59
2014-12-31 336.00 $71.60 4.69
2014-09-30 388.80 $77.04 5.05
2014-06-30 417.60 $81.69 5.11
2014-03-31 518.40 $76.20 6.80
2013-12-31 244.80 $41.32 5.92
2013-09-30 218.35 $35.19 6.21
2013-06-30 213.12 $22.05 9.66
2013-03-31 146.40 $33.68 4.35
2012-12-31 148.80 $38.33 3.88
2012-09-30 242.40 $23.86 10.16
2012-06-30 153.60 $38.61 3.98
2012-03-31 254.40 $43.60 5.83
2011-12-31 180.48 $53.92 3.35
2011-09-30 480.00 $51.27 9.36
2011-06-30 595.20 $57.87 10.28
2011-03-31 566.40 $86.39 6.56
2010-12-31 537.60 $59.31 9.06
2010-09-30 556.80 $106.08 5.25
2010-06-30 686.40 $100.41 6.84
2010-03-31 777.60 $54.96 14.15
2009-12-31 326.40 $32.73 9.97
2009-09-30 422.40 $40.06 10.54
2009-06-30 398.40 $24.56 16.22
2009-03-31 336.00 $16.28 20.64
Sector Industry Market Cap Revenue
$0.000B $0.000B
Ocuphire Pharma Inc. is a clinical-stage ophthalmic biopharmaceutical company. It is focused on developing and commercializing therapies for the treatment of several eye disorders. The company's product pipeline includes Nyxol Eye Drops(R) and APX3330. Ocuphire Pharma Inc., formerly known as Rexahn Pharmaceuticals Inc., is based in FARMINGTON HILLS, Mich.
Stock Name Country Market Cap PE Ratio
Fanhua (AIFU) China $0.086B 2.07
Top KingWin (WAI) China $0.008B 0.00
S&W Seed (SANW) United States $0.006B 0.00
Invo BioScience (NAYA) United States $0.004B 0.00